Why must pharma embrace climate intelligence now?

Even a 1℃ increase in temperature affects millions and will continue to do so over decades. From worsening allergies to cognitive decline, consumers are facing new health challenges due to climate change. In fact, the WHO estimates climate change causes an additional 150,000 deaths per year.

EY reveals that around 40% of consumers have felt climate change’s impact on their physical health, and 15% need healthcare due to climate-related illnesses. This increasing awareness is shaping consumer priorities and leading to new purchasing behaviors.

As much as it’s a challenge, it also presents an immense opportunity for the pharmaceutical industry to address climate impacts on health. For this to happen, they need access to climate data and robust collaboration with climate data providers.

This whitepaper explores how integrating climate data into pharmaceutical operations, marketing, and research can revolutionize the way health challenges are addressed. Climate data integration will help to:

✅Accelerate the development of precision medicine

✅Understand when and where to reach consumers for targeted marketing campaigns

✅Enhance consumer engagement and boost sales  

✅Avoid stockouts and optimize inventory levels to build supply chain resilience

Download the whitepaper to learn the roadmap for the pharmaceutical industry to navigate the challenges and opportunities presented by climate change.